Lincoln Medical & Mental Health Center

NEW YORK, Sept. 5, 2023 /PRNewswire/ -- Nina D'Abreo, MD, has been named as chief of the Division of Hematology and Medical Oncology at NYU Langone Health's Perlmutter Cancer Center–Sunset Park, effective September 1. Dr. D'Abreo previously served as the director of the Breast Medical Oncology Program at Perlmutter Cancer Center–Long Island, where she coordinated teams of physicians to assist patients from diagnosis to survivorship. Continue Reading Nina D'Abreo, MD Dr. D'Abreo has extensive clinical experience treating patients with breast cancer, having practiced in Mineola for 15 years. At Perlmutter Cancer Center–Sunset Park, she will lead a team of medical oncologists and other specialists that provide a full range of diagnostic services, treatments, and support programs for all types of cancer. She is also an assistant professor in the Department of Medicine at NYU Grossman School of Medicine. "The staff at Sunset Park recognizes the need for access and is committed to the population of Brooklyn," says Dr. D'Abreo. "Our goal is to offer the world-class care of an NCI-designated comprehensive cancer center, while maintaining a personalized and community experience." "Brooklyn is a microcosm of New York, with a diverse population, which is important for representation on clinical trials and health equity research," adds Dr. D'Abreo. Having served as the network principal investigator for co-operative and industry sponsored trials including research focused on optimizing HER2 and triple-negative breast cancer treatment, she plans to expand access not only to breast cancer trials but also other tumor types to Brooklyn-based patients. With 39 sites throughout Manhattan, Brooklyn, Queens, and Long Island, Perlmutter Cancer Center is the only full-service Comprehensive Cancer Center in Brooklyn with a local hospital (NYU Langone Hospital—Brooklyn) for acute care and surgery. "Dr. D'Abreo has been a proven leader at the Perlmutter Cancer Center for some time now," says Benjamin G. Neel, MD, PhD, director of the Perlmutter Cancer Center. "Delivering the highest-quality services to patients closer to home is part of our mission, and her track record with the patient population of Long Island will help us continue to grow our presence in Brooklyn." The center in Sunset Park, located at 5718 Second Avenue, offers medical appointments, chemotherapy, and radiation oncology at a single, convenient location, just two blocks south of NYU Langone Hospital–Brooklyn. Infusion treatments for neurological and rheumatologic conditions also are available at the site. For complex cases, the Sunset Park medical team is supported by the broader Perlmutter Cancer Center network of doctors, who can provide multidisciplinary consultation when needed. About Dr. D'Abreo An alumna of the University of Bombay in Mumbai, India, Dr. D'Abreo completed her residency and was chief medical resident at Lincoln Medical and Mental Health Center in the Bronx. She then completed her fellowship and was chief hematology/oncology fellow at Drexel University College of Medicine Hahnemann University Hospital. With her colleagues, Dr. D'Abreo participates in research which has been presented at national cancer conferences, such as the American Society of Clinical Oncology, and the San Antonio Breast Cancer Symposium, and published in high profile journals like the Journal of Clinical Oncology, and Nature Reviews Clinical Oncology. Media Inquiries Ryan Dziuba [email protected] (646) 581-8548 SOURCE NYU Langone Perlmutter Cancer Center

LOS ANGELES, Aug. 21, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Bharat Kothakota is acknowledged as a Top Pinnacle Professional for his contributions as an Entrepreneur and Emergency Physician. Dr. Kothakota began his educational journey in St. Louis where he earned a Bachelor of Science degree in Finance at Washington University in 2001. He then completed a Post Baccalaureate program in Pre-Medicine at the University of Maryland in 2004 and a Master's degree in International Public Health from George Washington in 2005. Continue Reading Bharat Kothakota The doctor continued his education at Howard University College of Medicine where he obtained his Medical Degree in 2009. He then completed his Internship in General Surgery at Howard University Hospital in 2010, and his Residency in Emergency Medicine at Lincoln Medical & Mental Health Center in 2014 before moving to Los Angeles. With more than 10 years of experience in his field, Dr. Kothakota, fondly referred to as Dr. K by many of his patients and colleagues, is a Board-Certified Emergency Physician specializing in aesthetic injections and procedures. He is also the owner of Self Care LA, a boutique aesthetics medical spa in Santa Monica and the Medical Director of Harmony Med Spa in Valencia, California. He notes that Emergency Medicine, also known as trauma and emergency medicine, is the medical specialty concerned with the care of life-threatening medical conditions or injuries requiring immediate medical attention. Emergency physicians are trained to care for a wide range of problems that require emergent medical help. These problems are often serious and may be life-threatening. Dedicated to providing the highest quality and latest treatments to patients, Dr. Kothakota and his team at Self Care LA specialize in using the latest energy-based treatments to produce exceptional improvements for the skin and body. They offer options like Clear + Brilliant® fractional treatments, EvolveX body contouring, and CoolSculpting®. He notes that Self-Care LA on Montana Avenue has a physician focus on aesthetic and injectable services. Adding to his extraordinary experience in the field, Dr. Kothakota has served as the Medical Director of Sollis Health in Beverly Hills, a concierge practice specializing in Emergency care (2021-2022). There, he was committed to accommodating the various unique needs of his members. He also served as the Medical Director of the Emergency Room at Olympia Medical Center (2015-2021). The doctor and his team at Beyond Harmony Med Spa offer numerous treatments to help their patients feel confident, including Botox and fillers; PDO thread lift; body contouring; laser Lipo, CoolSculpting®; laser hair removal; laser skin resurfacing; tattoo removal; and more. With skill and precision, the spa's purpose is to enhance each individual's natural beauty and to give them the confidence that they need and deserve. Inspired by his wife who asked him to treat her with Botox injections, Dr. Kothakota started a career in Medical Aesthetics. He has performed hundreds of procedures and has spent countless hours perfecting his craft in Medical Aesthetics. A testament to Dr. Kothakota's commitment to excellence, he is a member of the American College of Emergency Physicians and is board-certified in Emergency Medicine by the American Board of Emergency Medicine (ABEM). The doctor notes that the ABEM certifies Emergency Physicians who meet its educational, professional, and examination standards. In addition to his business and medical success, Dr. Kothakota's case report and literature review of a dissecting thoracic aneurysm in a 16-year-old boy presenting to the Emergency Department is published in the February 2014 Journal of Emergency Medicine. The doctor attributes his success to thinking outside the box and earning best practices from others. In his spare time, Dr. Kothakota enjoys time with his family, outdoors, travel, and dining out. He would like to dedicate this honor to Bhumika and thanks her for her love and support, and also in loving memory of his mother, Rama. Contact: Katherine Green, 516-825-5634, [email protected] SOURCE The Inner Circle

- A collaborative study demonstrates that AI analysis of Tertiary Lymphoid Structures (TLS) in tumors can predict treatment response in non-small cell lung cancer patients SEOUL, South Korea, Aug. 21, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of a groundbreaking study at the 2023 World Conference on Lung Cancer (WCLC 2023), to be held in Singapore on September 9-12. Co-led by Lunit, Northwestern University Feinberg School of Medicine, Ascension Saint Francis Hospital, and Lincoln Medical and Mental Health Center, the study explores the use of Lunit SCOPE IO - an AI-powered H&E analyzer which identifies Tertiary Lymphoid Structures (TLS) within the tumor microenvironment (TME) - to forecast immunotherapy treatment outcomes in lung cancer. The study builds on recent academic findings that the presence of TLS can serve as a predictive marker for the effectiveness of immuno-oncology treatment. A total of 85 patients with non-small cell lung cancer (NSCLC) who received immune checkpoint inhibitors (ICI) were analyzed for the study. According to the study, the utilization of Lunit SCOPE IO for TLS evaluation yielded clinically significant correlations with patients' overall survival (OS). 25 patients with detected TLS had notably prolonged overall survival compared to 60 patients without TLS. This correlation remained consistent irrespective of PD-L1 expression, a known biomarker for treatment response in NSCLC patients. These findings underscore the potential of AI-based TLS analysis as a biomarker for predicting treatment response in NSCLC patients. "Through rigorous collaboration and cutting-edge technology, our study illuminates a promising path toward better predicting lung cancer treatment outcomes. The potential of TLS analysis via Lunit SCOPE IO in predicting immunotherapy response represents a meaningful step forward in better understanding cancer biology, and making AI analysis of the TME an actionable part of cancer care," said Brandon Suh, CEO of Lunit. Lunit SCOPE IO was developed with a dataset of thousands of Hematoxylin and Eosin (H&E) stained whole-slide images derived from 18 different types of cancer from patients around the world. About Lunit Lunit is a deep learning-based medical AI company on a mission to conquer cancer. Our focus is on developing AI solutions for precision diagnostics and therapeutics, ensuring the right diagnosis, and treatment, at the right cost for each patient. Lunit is devoted to developing advanced medical image analytics and AI-based biomarkers via cutting-edge technology. Founded in 2013, Lunit has been acknowledged around the world for its advanced, state-of-the-art technology and its application in medical images. Its technology has been recognized at international AI competitions, surpassing giants like Google, IBM, and Microsoft. As a medical AI company grounded on clinical evidence, the company's findings are presented in major peer-reviewed journals, such as the Journal of Clinical Oncology and JAMA Network Open, and global conferences, including ASCO and AACR. After receiving FDA clearance and the CE Mark, our flagship Lunit INSIGHT suite is clinically used in approximately 2,500 hospitals and medical institutions across 40+ countries. Lunit is headquartered in Seoul, South Korea, with offices and representatives worldwide. For more information, please visit lunit.io About Lunit SCOPE Lunit SCOPE is a suite of AI-powered software that analyzes tissue slide images for digital pathology and AI biomarker development, aiming to optimize workflow and facilitate more accurate and predictive clinical data for clinicians and researchers. Lunit SCOPE platform offers multiple AI-powered tissue analysis products and assays that can streamline digital pathology workflow and diagnostics and enhance the drug development process. Lunit SCOPE IO analyzes the tumor microenvironment (TME) based on H&E analysis and provides AI-based predictive clinical outcome information. In addition, AI-driven Immunohistochemistry (IHC) slide analysis services are offered, through products such as Lunit SCOPE PD-L1, Lunit SCOPE HER2, Lunit SCOPE ER/PR, and others. SOURCE Lunit